Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Teradata Corp
TDC
5
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
PDSB PDS Biotechnology
- 1.280
- +0.030+2.40%
Trading Apr 28 10:21 ET
58.11MMarket Cap-1.24P/E (TTM)
1.285High1.225Low41.57KVolume1.230Open1.250Pre Close52.36KTurnover0.10%Turnover RatioLossP/E (Static)45.40MShares4.42052wk High3.05P/B56.29MFloat Cap0.85152wk Low--Dividend TTM43.98MShs Float17.850Historical High--Div YieldTTM4.77%Amplitude0.615Historical Low1.259Avg Price1Lot Size
About PDS Biotechnology Company
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo in 2005 and is headquartered in Princeton, NJ.
Company Profile
SymbolPDSB
Company NamePDS Biotechnology
Listing DateOct 1, 2015
Issue Price11.00
Founded2005
CEODr. Frank Bedu-Addo, PhD
MarketNASDAQ
Employees24
Fiscal Year Ends12-31
Address303A College Road East
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540
Phone1-800-208-3343
Websitehttp://www.pdsbiotech.com
Company Executives
- Name
- Position
- Salary
- Dr. Frank Bedu-Addo, PhD
- Director, President and Chief Executive Officer
- 5.01M
- Stephan F. Toutain, M.B.A.,M.S.
- Chief Operations Officer
- --
- Spencer D. Brown
- Senior Vice President, General Counsel and Chief Compliance Officer
- --
- Lars Boesgaard
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Kirk V. Shepard, M.D.
- Chief Medical Officer
- --
- Dr. Gregory L. Conn, PhD
- Chief Scientific Officer
- 1.68M
- Stephen C. Glover
- Chairman of the Board
- 135.99K
- Dr. Ilian Petkov Iliev, PhD
- Director
- 82.99K
- Kamil Ali-Jackson, Esq.
- Independent Director
- 106.49K
- Gregory G. Freitag, C.P.A.,J.D.
- Independent Director
- 105.49K
- Dr. Otis W. Brawley,M.D.
- Independent Director
- 82.99K
- Sir Richard Brook Sykes
- Independent Director
- 94.49K
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now